RE: RNS fundraising5 Feb 2026 19:56
Interesting AI search
Based on 2025 financial reports and updates from Tooru PLC (formerly S-Ventures PLC), which owns both brands, the sales and performance for Pulsin and Juvela are as follows:
Overall Portfolio (Juvela + Pulsin + Market Rocket): The total portfolio was forecasted to generate £14.3 million in sales for FY24 (ending December 2024), with projections to rise significantly, supported by a 170% annualized revenue growth to £20 million reported in early 2025.
Juvela: The gluten-free brand has remained profitable, with EBITDA consistently in excess of £2 million. It has seen strong performance in 2025, including continued success in Tesco and securing a new listing with another major UK retailer for 2026.
Pulsin: Following a restructure, the plant-based brand returned to profitability in early 2025. It has focused on increasing its store count and secured a new European distributor, with sales expected to commence in early 2026.
Outlook: 2025 was considered a solid year, with 2026 focused on expanding distribution for both brands, with the portfolio overall expected to surpass £20 million in sales in FY26.
Note: Juvela was acquired for £8m and Pulsin for £7.5m, with the combined portfolio valued by some estimates at c.£31m in 2025.